A new AI algorithm leveraging cardiac MRI and health data significantly outperforms current clinical guidelines in predicting risk of sudden cardiac arrest in hypertrophic cardiomyopathy patients.
Key Details
- 1The AI model, MAARS, uses cardiac MRI, electronic health records, and echocardiogram data.
- 2Developed and validated on cohorts of 553 and 284 patients, respectively.
- 3MAARS achieved 89% overall accuracy and 93% accuracy for high-risk patients aged 40-60.
- 4Outperformed traditional clinical guidelines (approx. 50% accuracy) and other tools in sensitivity, specificity, and AUROC (0.89 for MAARS).
- 5Could reduce unnecessary implantable defibrillators and more precisely identify at-risk patients.
Why It Matters

Source
AuntMinnie
Related News

Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.

AI Models Reveal Racial Disparities in Breast Cancer Patterns
Machine learning models reveal significant racial disparities and key predictors in breast cancer incidence across diverse groups.

UCLA Appoints Inaugural Associate Dean for Health AI Strategy
UCLA has appointed Katherine P. Andriole as its first associate dean for Health AI Strategy and Innovation, with an initial focus on radiology.